NervGen Pharma
Dan Mikol, MD, PhD, has over 25 years of experience in the pharmaceutical industry and as a practicing neurologist conducting clinical research. For 12 years, he was an active clinician and clinical researcher in the Department of Neurology at the University of Michigan, specializing in the treatment of multiple sclerosis, where he rose to the level of Associate Professor. For the past 14 years, Dr. Mikol has had leadership roles in neuroscience clinical development and medical affairs.
This person is not in any offices
NervGen Pharma
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.